相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection
Jill Hochreiter et al.
ANTIVIRAL THERAPY (2013)
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
Maria Teresa Catanese et al.
JOURNAL OF VIROLOGY (2013)
The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
Kathleen N. Ly et al.
ANNALS OF INTERNAL MEDICINE (2012)
HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents
Beatriz Calle Serrano et al.
ANTIVIRAL THERAPY (2012)
Evaluation of ITX 5061, a Scavenger Receptor B1 Antagonist: Resistance Selection and Activity in Combination With Other Hepatitis C Virus Antivirals
Haihong Zhu et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases
Marc G. Ghany et al.
HEPATOLOGY (2011)
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Andrew J. Syder et al.
JOURNAL OF HEPATOLOGY (2011)
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
Mirjam B. Zeisel et al.
JOURNAL OF HEPATOLOGY (2011)
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner et al.
NATURE (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Helen J. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies
Simrat Dhillon et al.
JOURNAL OF VIROLOGY (2010)
Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor
David Masson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
Joe Grove et al.
JOURNAL OF VIROLOGY (2008)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Persistent hepatitis C virus infection in vitro: Coevolution of virus and host
Jin Zhong et al.
JOURNAL OF VIROLOGY (2006)
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
B Bartosch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI
TJF Nieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
F Imbert-Bismut et al.
LANCET (2001)
分享论文
